Joukje C. Wanten

Joukje C. Wanten

Auto-generated profile, based on publicly available information

Joukje C. Wanten

University Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, the Netherlands

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2023 in JMIR Formative Research
Verified
Journal Article
Open access
JCJanneau Claessens
Janneau Claessens
JEJuultje van Egmond
Juultje van Egmond
JWJoukje Wanten
Joukje Wanten
P2P Debijelaan 25
P Debijelaan 25
RNRudy Nuijts
Rudy Nuijts
RWRobert Wisse
Robert Wisse
Background: Telehealth solutions can play an important role in increasing access to eye care. Web-based eye tests can enable individuals to self-assess their visual function remotely without the assistance of an eye care professional. A web-based tool for self-assessing visual acuity (VA) has previously been studied in controlled, supervised conditions. The accuracy of this tool when performed independently by patients in their home environment, using their own devices, has not yet been examined. Objective: The objective of this paper was to examine the accuracy of a web-based tool with respect to measuring VA in ophthalmic patients in their home environment, compared with a conventional in-hospital assessment using a Snellen chart (the gold standard). Methods: From April through September 2020, consecutive adult patients with uveitis at the University Medical Center Utrecht, the Netherlands, performed the web-based VA test at home (the index test) before their upcoming conventional VA assessment at the hospital (the reference test). The agreement between the 2 tests was assessed by the Bland-Altman analysis. Additional analyses were performed to investigate associations between clinical characteristics and the accuracy of the web-based test. Results: A total of 98 eyes in 59 patients were included in the study. The difference in VA between the index and reference tests was not significant, with a mean difference of 0.02 (SD 0.12) logMAR (P=.09) and 95% limits of agreement of –0.21 to 0.26 logMAR. The majority of the differences (77%) fell within the predetermined acceptable deviation limit of 0.15 logMAR. In addition, no patient characteristics or clinical parameters were found to significantly affect the accuracy of the web-based test. Conclusions: This web-based test for measuring VA is a valid tool for remotely assessing VA, also when performed independently by patients at home. Implementation of validated web-based tools like this in the health care system may represent a valuable step forward in revolutionizing teleconsultations and can provide individual patients with the opportunity to self-monitor changes in VA. This is particularly relevant when the patient’s access to ophthalmic care is limited. Future developments should focus on optimizing the testing conditions at home to reduce outliers.

1 May 2025 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Open access
JWJoukje C. Wanten
Joukje C. Wanten
P2P Debijelaan 25
P Debijelaan 25
TBTos TJM Berendschot
Tos TJM Berendschot
FBFrank Van Den Biggelaar
Frank Van Den Biggelaar
RNRudy M.M.A. Nuijts
Rudy M.M.A. Nuijts
Purpose: To evaluate the symptoms, etiology, and treatment of patient dissatisfaction after extended depth-of-focus (EDOF) intraocular lens (IOL) implantation. Setting: University Eye Clinic, Maastricht University Medical Center, the Netherlands. Design: Retrospective case series. Methods: For this study, all medical records of patients who received an EDOF IOL from July 2020 to July 2022 were reviewed. Patients were included if they had reported any dissatisfaction after surgery. The main outcome parameters were reasons for dissatisfaction (subjective complaints) and the presumed etiology of the complaints. Results: Of 202 patients (354 eyes) who underwent EDOF IOL implantation, 83 eyes (22.8%) of 52 dissatisfied patients were included. Blurred vision was the predominant complaint, reported in 78 eyes (94%). Photic phenomena were reported in 21 eyes (25.3%), with 16 eyes (76.2%) experiencing coexisting blurred vision. The major etiologies for dissatisfaction in this cohort were residual ametropia (51.8%), dry eye disease (26.5%), and posterior capsular opacification (12.0%). Treatments were administered to 85.5% of the eyes, including interventions such as artificial tears, spectacles, or refractive surgery enhancement. A small number of patients (n = 12; 5.9%) remained dissatisfied despite intervention. Conclusions: Based on this real-world data study, dissatisfaction after EDOF IOL implantation can be effectively identified and treated in most cases.

24 April 2025 in American Journal of Ophthalmology
Verified
Journal Article
Open access
JWJoukje C. Wanten
Joukje C. Wanten
P2P Debijelaan 25
P Debijelaan 25
TBTos TJM Berendschot
Tos TJM Berendschot
FBFrank Van Den Biggelaar
Frank Van Den Biggelaar
RNRudy M.M.A. Nuijts
Rudy M.M.A. Nuijts
To compare the visual outcomes of two extended depth-of-focus (EDOF) intraocular lenses (IOLs). Single-center prospective randomized controlled trial. Patients undergoing bilateral cataract surgery were randomly assigned to receive either the Acunex Vario IOL (Teleon Surgical B.V., Spankeren, The Netherlands) or the AcrySof IQ Vivity IOL (Alcon Laboratories Inc., Fort Worth, United States of America); both Vario-group and Vivity-group were targeted for mini-monovision. The primary outcome was the uncorrected intermediate visual acuity (UIVA, measured at 66cm). Secondary outcome parameters were uncorrected distance visual acuity (UDVA), uncorrected near visual acuity (UNVA), defocus curves, reading speed, contrast sensitivity, spectacle independence and quality of vision. University Eye Clinic, Maastricht University Medical Center+, the Netherlands. A total of 31 subjects (62 eyes) were included, 16 patients were enrolled into the Vario-group and 15 patients into the Vivity-group. At three months postoperatively, no statistically significant differences were found for the binocular visual acuities between the groups after adjustment for covariates. The mean and standard deviation for the binocular UIVA was 0.04±0.11 and 0.15±0.11 logMAR (adjusted-P=0.264) for the Vario-group and Vivity-group, respectively. The binocular UDVA was 0.00±0.14 and 0.08±0.10 logMAR (adjusted-P=0.753), and UNVA was 0.22±0.17 and 0.31±0.14 logMAR (adjusted-P=0.235), for both groups, respectively. While the Vario-group had a larger range of defocus, no significant differences were found for patient satisfaction and spectacle independence. Contrast sensitivity and reading speed were comparable, and there were no statistically significant differences in optical side effects between the groups. Bilateral implantation of the Acunex Vario IOL and the AcrySof IQ Vivity IOL targeted for mini-monovision had comparable results for binocular visual acuity outcomes, contrast sensitivity, optical side effects, and reading speed. The Vario-group showed a larger continuous range of defocus.

6 December 2022 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Open access
JWJoukje C. Wanten
Joukje C. Wanten
NBNoël J.C. Bauer
Noël J.C. Bauer
JCJanneau L.J. Claessens
Janneau L.J. Claessens
TAThomas van Amelsfort
Thomas van Amelsfort
TBTos T.J.M. Berendschot
Tos T.J.M. Berendschot
RNRudy M.M.A. Nuijts
Rudy M.M.A. Nuijts
Purpose: To validate the Easee web-based tool for the assessment of visual acuity in patients who underwent cataract surgery. Setting: University Eye Clinic Maastricht, Maastricht, the Netherlands. Design: Prospective method comparison study. Methods: Subjects aged between 18 and 69 years who underwent cataract surgery on 1 or both eyes at the Maastricht University Medical Center+ were eligible to participate in this study. The uncorrected (UDVA) and corrected distance visual acuity (CDVA) assessments were performed using the web-based tool (index test) and conventional ETDRS and Snellen charts (reference tests). The outcomes of the different tests were expressed in logMAR, and a difference of <0.15 logMAR was considered clinically acceptable. Results: 46 subjects with 75 operated eyes were included in this study. The difference of the UDVA between the web-based tool and ETDRS or Snellen was −0.05 ± 0.10 logMAR (P < .001 [0.15; −0.26]) and −0.04 ± 0.15 logMAR (P = .018 [0.24; −0.33]), respectively. For the CDVA, these differences were −0.04 ± 0.08 logMAR (P < .001 [0.13; −0.21]) and −0.07 ± 0.10 logMAR (P < .001 [0.13; −0.27]), respectively. The Pearson correlation coefficients between the web-based tool and ETDRS were maximally 0.94 and compared with Snellen 0.92. In total, 73% to 88% of the visual acuity measurement differences were within 0.15 logMAR. Conclusions: The web-based tool was validated for the assessment of visual acuity in patients who underwent cataract surgery and showed clinically acceptable outcomes in up to 88% of patients. Most of the participants had a positive attitude toward the web-based tool, which requires basic digital skills.

1 September 2024 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Open access
JCJanneau L.J. Claessens
Janneau L.J. Claessens
JWJoukje C. Wanten
Joukje C. Wanten
P2P Debijelaan 25
P Debijelaan 25
RNRudy M.M.A. Nuijts
Rudy M.M.A. Nuijts
VVViolette Vrijman
Violette Vrijman
RWRobert Wisse
Robert Wisse
Purpose: To compare web-based, self-administered follow-up after cataract surgery to conventional face-to-face follow-up. Setting: Eye clinics in the Netherlands, Austria, and Germany. Design: Randomized controlled trial with an embedded method comparison study (ClinicalTrials.gov: NCT04809402). Methods: Routine patients with cataract were randomized into 2 groups: The telemonitoring group undertook web-based vision self-assessments and questionnaires from home, while the usual care group received conventional care. All participants had a 4- to 6-week postoperative clinic visit for safety and validation purposes. Outcomes included, the web test's accuracy for assessing postoperative visual acuity (VA) and refractive error, adverse event rates, and patient-reported outcome measurements (PROMs). Results: 94 participants (188 eyes) were enrolled. Web-based uncorrected distance VA testing demonstrated a negligible mean difference (−0.03 ± 0.14 logMAR) when compared with conventional Early Treatment Diabetic Retinopathy Study chart testing, with 95% limits of agreement ranging from −0.30 to 0.24 logMAR. The web-based refraction assessment overestimated the postoperative refractive error (mean difference in spherical equivalent 0.15 ± 0.67 diopters), resulting in a poorer corrected distance VA compared with subjective refraction (mean 0.1 vs −0.1 logMAR). Rates of adverse events and unscheduled consultations were minimal across both groups. Preoperative and postoperative PROM questionnaires had a 100% response rate. Visual functioning (Catquest-9SF and National Eye Institute Visual Function Questionnaire-25) improved postoperatively (mean improvement −0.80 and 16.70, respectively) and did not significantly differ between the 2 groups. Conclusions: The patients with cataract in this study effectively provided postoperative outcome data using a web interface. Both conventional and web-based follow-ups yielded similar PROMs and adverse event rates. Future developments should reduce the variability in the web-based VA test and yield representative refraction outcomes.

1 November 2025 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Open access
JWJoukje C. Wanten
Joukje C. Wanten
JCJulián Cezón
Julián Cezón
RNRudy M.M.A. Nuijts
Rudy M.M.A. Nuijts
JCJuan A. Duran de la Colina
Juan A. Duran de la Colina
MRMariano Royo
Mariano Royo
JGJosé L. Güell
José L. Güell
Purpose: To evaluate the 6-month effectiveness and safety of a new foldable multifocal iris-fixated phakic intraocular lens (pIOL) for presbyopia correction. Setting: Multicenter study at 7 sites. Design: Nonrandomized prospective clinical trial. Methods: Presbyopic patients without cataracts undergoing bilateral multifocal pIOL implantation (Ophtec ArtiPlus) were studied. The primary outcome for efficacy was the visual acuity at distance, intermediate, and near. Secondary outcomes included endothelial cell density (ECD), postoperative refraction, binocular defocus curve, vision quality, spectacle independence, and patient satisfaction. Results: 49 subjects (98 eyes) were included. At 6 months, the mean binocular uncorrected distance intermediate, and near visual acuity was −0.05 ± 0.09 logMAR, −0.02 ± 0.07 logMAR, and 0.02 ± 0.08 logMAR, respectively. The ECD remained stable with a mean value of 2771 ± 289 cells/mm 2 at 6 months postoperatively. The mean spherical equivalent was −0.42 ± 0.33 diopters (D), with 95% eyes having a prediction error within ±1.0 D and 77% within ±0.5 D. The binocular distance-corrected defocus curve showed a visual acuity of 0.20 logMAR or better over a range of +1.0 to −3.5 D. Patient satisfaction was high, with a mean score of 3.5 on a 4-point scale, and 83% of the patients reported spectacle independence. 47%, 35%, and 96% of patients reported experiencing glare, halos, and starbursts at well-tolerated levels, respectively. Notably, only 2% of patients found halos and starbursts to be very bothersome. Conclusions: Bilateral ArtiPlus multifocal pIOL implantation demonstrated good visual acuity from distant to near and maintained stable ECD over 6 months. Patients reported high levels of satisfaction and spectacle independence, despite some optical disturbances.